Search

Acute kidney injury (AKI) is characterized by impaired renal function that can result in irreversible severe renal impairment or lifelong dependence on renal replacement therapy in some cases. Early intervention can significantly slow down the progression of AKI and reduce mortality. In recent years, electronic early warning systems for patients with AKI have been gaining attention as a potential clinical decision‐support option. This paper presents a review of the application of electronic early warning systems for AKI from four aspects: development process, types of output, influencing factors, and system evaluation. [ABSTRACT FROM AUTHOR]

Background. The association between patient demographics and CV events after ADT using real‐world data was evaluated. In addition to encompassing >30 times more patients than all previous MACE studies, this is the first study, to the best of our knowledge, to include a comprehensive listing of many demographic factors from one large, recent US dataset over a long period of time. Materials and Methods. The retrospective analysis of data in the Decision Resources Group (now Clarivate) Real World Evidence repository, representing >300M US patients from 1991 to 2020 across all US regions, was performed. Patients with PCa receiving ≥1 ADT injection were included. MACE risk after ADT initiation was evaluated for demographic and potential PCa‐related risk factors. Kaplan–Meier survival curves were constructed, and Cox regression was used to evaluate the association between MACE risk and demographic/PCa‐related risk factors. Results. Overall, MACE risk was slightly lower in the first year after ADT initiation (3.9%) vs. years 2–4 (∼5.2%). In a multivariate Cox model, MACE risk after ADT initiation was significantly higher for older vs. younger patients (adjusted HR per increasing year = 1.08, 95% CI: 1.07–1.09), men with a history of MACE vs. without (HR = 2.22, 95% CI: 1.72–2.88), men with very low BMI vs. normal or high BMI (HR for decreasing BMI per kg/m2 = 1.02, 95% CI: 1.01–1.03), White vs. Black patients (HR = 1.30, 95% CI: 1.08–1.55), and patients who did not use statins vs. those who did (HR = 1.13, 95% CI: 1.00–1.27). Of the PCa‐related risk factors, MACE risk after ADT initiation was significantly higher for oncology vs. urology treatment setting (HR = 2.47, 95% CI: 2.12–2.88), patients with baseline metastasis vs. those without (HR = 2.30, 95% CI: 1.72–3.07), and patients treated with antagonists vs. agonists (HR = 1.62, 95% CI: 1.25–2.10). Conclusions. Demographic factors are important contributors to increased MACE risk for men with PCa on ADT. Clinicians should monitor risk factors and modify if possible. [ABSTRACT FROM AUTHOR]

The Tibetan Plateau (TP), with its unique geographical and climatic conditions, holds a significant role in global climate change. Therefore, it is particularly urgent to fully understand its vegetation phenology. Herbaceous plants are widely distributed in the TP. However, previous studies have predominantly examined the impact of air temperature on the end date of the vegetation growing season (EOS), with less emphasis on the influence of land surface temperature (LST). In this study, the dynamic changes in the EOS from 2001 to 2020 were analyzed by utilizing the Normalized Difference Vegetation Index (NDVI) data published by NASA. Furthermore, the impact of climate change on the EOS was examined, and the dominant factor (air temperature, LST, or precipitation) influencing the EOS was identified. The main findings were as follows: the average annual EOS predominantly occurred between day of year (DOY) 240 and 280, with an advance from the edge of the plateau to the center. The EOS across the entire region displayed a marginal tendency towards delay, with an average rate of 0.017 days/year. Among all vegetation, shrubs showed the most pronounced delay at a rate of 0.04 days/year. In terms of precipitation, the impact of climate change increased precipitation in both summer and autumn, which could delay EOS. In terms of temperature, an increase in summer Tmin, autumn air temperatures and summer LST delayed the EOS, while an increase in autumn LST advanced the EOS. Compared to air temperature and precipitation, LST had a stronger controlling effect on the EOS (the largest pixel area dominated by LST). These results could offer new insights for enhancing the parameters of vegetation phenology models across the TP. [ABSTRACT FROM AUTHOR]

Isoliquiritigenin (ISL) has excellent neuroprotective effects. However, its limitations, including poor solubility, low bioavailability, and low accumulation in the brain, restrict its clinical promotion. In this study, a novel type of ISL-loaded liposome (ISL-LP) modified with the brain-targeting polypeptide angiopep-2 was prepared to improve these properties. The zeta potential, morphology, particle size, encapsulation efficiency, drug loading, and in vitro release of ISL-LP were evaluated. The pharmacokinetics and tissue distribution of ISL and ISL-LP were also investigated. The results demonstrated that ISL-LP had an average particle size of 89.36 ± 5.04 nm, a polymer dispersity index of 0.17 ± 0.03, a zeta potential of −20.27 ± 2.18 mV, and an encapsulation efficiency of 75.04 ± 3.28%. The in vitro release experiments indicate that ISL-LP is a desirable sustained-release system. After intravenous administration, LPC-LP prolonged the circulation time of ISL in vivo and enhanced its relative brain uptake. In conclusion, ISL-LP could serve as a promising brain-targeting system for the treatment and prevention of central nervous system (CNS) disorders. [ABSTRACT FROM AUTHOR]

Background. Photodynamic diagnosis‐assisted transurethral resection of bladder tumors (PDD‐TURBT) enhances detection of elusive lesions compared to standard white light‐transurethral resection of bladder tumors (WL‐TURBT). If minimal light exposure during PDD‐TURBT induces the accumulation of reactive oxygen species (ROS), potentially resulting in phototoxicity in small lesions, apoptosis may be triggered in residual small tumors, allowing them to escape resection. We investigated the hypothesis of a potential photodynamic therapeutic effect during PDD‐TURBT. Methods and Materials. Our study, conducted between January 2016 and December 2020 at Nara Medical University Hospital, focused on a specific emphasis on ROS production. Immunohistochemical analysis for thymidine glycol and Nε‐hexanoyl‐lysine was performed on 69 patients who underwent 5‐aminolevulinic acid‐mediated PDD‐TURBT and 28 patients who underwent WL‐TURBT. Additionally, we incrementally applied the minimal irradiation energy to T24 and UM‐UC‐3 cells treated with 5‐aminolevulinic acid using instruments similar to those used in PDD‐TURBT and evaluated intracellular ROS production and phototoxicity. Results. Immunohistochemical analysis revealed a significant increase in production of thymidine glycol and Nε‐hexanoyl‐lysine within the PDD‐TURBT group. In T24 and UM‐UC‐3 cells treated with 5‐aminolevulinic acid and light exposure, immunofluorescent staining demonstrated a dose‐dependent increase in intracellular ROS production. In addition, higher irradiation energy levels were associated with a greater increase in ROS production and phototoxicity, as well as more significant decrease in mitochondrial membrane potential. Conclusion. Although the irradiation energy used in PDD‐TURBT did not reach the levels commonly used in photodynamic therapy, our findings support the presence of a potential cytotoxic effect on bladder lesions during PDD‐TURBT. [ABSTRACT FROM AUTHOR]

Background. Although routine surveillance imaging to examine upper urinary tract urothelial cancer recurrence during follow‐up of nonmuscle invasive bladder cancer is recommended, its necessity remains invalidated. A single‐institute long‐term follow‐up cohort study to evaluate the clinical impact of routine surveillance imaging and identify risk factors for upper urinary tract urothelial cancer recurrence after nonmuscle invasive bladder cancer treatment was conducted. Methods and Materials. A retrospective chart review of 864 patients with primary nonmuscle invasive bladder cancer who underwent initial transurethral resection of bladder tumor between 1980 and 2020 was conducted. The opportunities to diagnose its recurrence were examined. Moreover, oncological outcomes included upper urinary tract urothelial cancer recurrence‐free survival and overall survival. Results. Of 864 patients, 19 (2.2%) experienced upper urinary tract urothelial cancer recurrence. Among 19 patients, recurrence was detected through routine imaging in 12 (63.2%), cystoscopy in 2 (10.5%), urine cytology in 2 (10.5%), and presence of gross hematuria in 1 (5.3%). All patients had high‐ or highest‐risk NMIBC at diagnosis of primary nonmuscle invasive bladder cancer. On multivariate Fine‐Gray proportional regression analyses, a tumor size of ≥30 mm and carcinoma in situ were independently associated with short upper urinary tract urothelial cancer recurrence‐free survival (P = 0.040 and 0.0089, respectively). Conclusion. Most patients experiencing upper urinary tract urothelial cancer recurrence were diagnosed by routine surveillance imaging, suggesting its clinical importance, especially for patients with nonmuscle invasive bladder cancer accompanied by a tumor size of ≥30 mm and carcinoma in situ. [ABSTRACT FROM AUTHOR]